Veículo
CIDRAP - Center for Infectious Disease Research and Policy (EUA)
Em 2025: 0 notícias
Desde 1995: 3 notícias
New single-dose dengue vaccine shows 80% protection
Publicado em 02 de fevereiro de 2024
Results of a phase 3 trial in the New England Journal of Medicine NEJM ) show 80% protection for the single-dose tetravalent (four-strain) Butantan-Dengue
Vaccine (Butantan D-V) among participants with no evidence of previous dengue exposure and 89% protection in those with a history of exposure.
The vaccine is the culmination of years of research from Brazil's Butantan Institute, and the study included results from 16 Brazilian centers located in all five regions of the country. Each [...]
-
Studies add to picture of how COVID can affect the brain long term
Publicado em 03 julho 2023New studies on SARS-CoV-2's neurologic effects describe how even mild infections can lead to neuropsychiatric conditions by altering brain structure and function and review possible mechanisms for viral passage through the blood-brain barrier. More anxiety, reduced ability to work Even mild COVID-19 infections can alter brain structures and functions, leading to neuropsychiatric conditions such as anxiety, depression, fatigue, and sleepiness and undermining well-being, health, and the [...]ver notícia -
Brain changes may be linked to anxiety, depression in long COVID
Publicado em 01 julho 2022People who have long COVID and experience anxiety and depression following a mild infection may have brain changes that affect its structure and function, Brazilian researchers reported yesterday at the American Academy of Neurology (AAN) annual meeting in Boston. The team, from the University of Campinas in Sao Paulo, assessed 254 people who had mild COVID 3 months earlier. Of the group, 102 (40.2%) had both anxiety and depression symptoms, and 152 (59.8%) had no symptoms. The participants, [...]ver notícia